Skip Nav Destination
Telomere length and telomerase activity delineate distinctive replicative features of the B-CLL subgroups defined by immunoglobulin V gene mutations
BEAM-alemtuzumab reduced-intensity allogeneic stem cell transplantation for lymphoproliferative diseases: GVHD, toxicity, and survival in 65 patients
Reduced-intensity preparative regimen and allogeneic stem cell transplantation for advanced solid tumors
Clinical significance of HOX11L2 expression linked to t(5;14)(q35;q32), of HOX11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: results of EORTC studies 58881 and 58951
Clonal evolution and lack of cytogenetic response are adverse prognostic factors for hematologic relapse of chronic phase CML patients treated with imatinib mesylate
Intravenously applied IgG stimulates complement attenuation in a complement-dependent autoimmune disease at the amplifying C3 convertase level
Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndrome
A phase 3 study of three induction regimens and of priming with GM-CSF in older adults with acute myeloid leukemia: a trial by the Eastern Cooperative Oncology Group
Unrelated cord blood transplantation for adult patients with de novo acute myeloid leukemia
Congenital thrombotic thrombocytopenic purpura in association with a mutation in the second CUB domain of ADAMTS13
Naturally occurring anti–IFN-γ autoantibody and severe infections with Mycobacterium cheloneae and Burkholderia cocovenenans
Prognostic significance of bcl-xL gene expression and apoptotic cell counts in follicular lymphoma
Issue Archive
January 15 2004
Table of Contents
INSIDE BLOOD
PLENARY PAPERS
Telomere length and telomerase activity delineate distinctive replicative features of the B-CLL subgroups defined by immunoglobulin V gene mutations
Clinical Trials & Observations
Rajendra N. Damle,Franak M. Batliwalla,Fabio Ghiotto,Angelo Valetto,Emilia Albesiano,Cristina Sison,Steven L. Allen,Jonathan Kolitz,Vincent P. Vinciguerra,Prasad Kudalkar,Tarun Wasil,Kanti R. Rai,Manlio Ferrarini,Peter K. Gregersen,Nicholas Chiorazzi
RETRACTIONS
REVIEWS IN TRANSLATIONAL HEMATOLOGY
CHEMOKINES
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS
BEAM-alemtuzumab reduced-intensity allogeneic stem cell transplantation for lymphoproliferative diseases: GVHD, toxicity, and survival in 65 patients
Clinical Trials & Observations
Rowena D. Faulkner,Charles Craddock,Jennifer L. Byrne,Prem Mahendra,Andrew P. Haynes,Hugh G. Prentice,Michael Potter,Antonio Pagliuca,Aloysius Ho,Stephen Devereux,Grant McQuaker,Ghulam Mufti,John Liu Yin,Nigel H. Russell
Reduced-intensity preparative regimen and allogeneic stem cell transplantation for advanced solid tumors
Clinical Trials & Observations
Didier Blaise,Jacques Olivier Bay,Catherine Faucher,Mauricette Michallet,Jean-Michel Boiron,Bachra Choufi,Jean-Yves Cahn,Nicole Gratecos,Jean-Jacques Sotto,Sylvie François,Joel Fleury,Mohamad Mohty,Christian Chabannon,Karin Bilger,Gwenaelle Gravis,Frédéric Viret,Anne Chantal Braud,Valérie Jeanne Bardou,Dominique Maraninchi,Patrice Viens
Clinical significance of HOX11L2 expression linked to t(5;14)(q35;q32), of HOX11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: results of EORTC studies 58881 and 58951
Clinical Trials & Observations
Hélène Cavé,Stefan Suciu,Claude Preudhomme,Bruce Poppe,Alain Robert,Anne Uyttebroeck,Michèle Malet,Patrick Boutard,Yves Benoit,Laurent Mauvieux,Patrick Lutz,Françoise Méchinaud,Nathalie Grardel,Françoise Mazingue,Madeleine Dupont,Geneviève Margueritte,Marie-Pierre Pages,Yves Bertrand,Emmanuel Plouvier,Ghislaine Brunie,Christian Bastard,Dominique Plantaz,Isabel Vande Velde,Anne Hagemeijer,Frank Speleman,Michel Lessard,Jacques Otten,Etienne Vilmer,Nicole Dastugue,the EORTC-CLG
Clonal evolution and lack of cytogenetic response are adverse prognostic factors for hematologic relapse of chronic phase CML patients treated with imatinib mesylate
Clinical Trials & Observations
Michael E. O'Dwyer,Michael J. Mauro,Carolyn Blasdel,Melanie Farnsworth,Gwen Kurilik,Yi-Ching Hsieh,Motomi Mori,Brian J. Druker
Intravenously applied IgG stimulates complement attenuation in a complement-dependent autoimmune disease at the amplifying C3 convertase level
Clinical Trials & Observations
Hans U. Lutz,Pia Stammler,Valentina Bianchi,Ralph M. Trüeb,Thomas Hunziker,Reinhard Burger,Emiliana Jelezarova,Peter J. Späth
Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndrome
Clinical Trials & Observations
Amy D. Klion,Jamie Robyn,Cem Akin,Pierre Noel,Margaret Brown,Melissa Law,Dean D. Metcalfe,Cynthia Dunbar,Thomas B. Nutman
A phase 3 study of three induction regimens and of priming with GM-CSF in older adults with acute myeloid leukemia: a trial by the Eastern Cooperative Oncology Group
Clinical Trials & Observations
Jacob M. Rowe,Donna Neuberg,William Friedenberg,John M. Bennett,Elisabeth Paietta,Adel Z. Makary,Jane L. Liesveld,Camille N. Abboud,Gordon Dewald,F. Ann Hayes,Martin S. Tallman,Peter H. Wiernik
Unrelated cord blood transplantation for adult patients with de novo acute myeloid leukemia
Clinical Trials & Observations
Brief Report
Jun Ooi,Tohru Iseki,Satoshi Takahashi,Akira Tomonari,Kashiya Takasugi,Yoko Shimohakamada,Toshiki Yamada,Koji Ishii,Nobuhiro Ohno,Fumitaka Nagamura,Kaoru Uchimaru,Arinobu Tojo,Shigetaka Asano
GENE THERAPY
HEMATOPOIESIS
Ultrastructural study shows morphologic features of apoptosis and para-apoptosis in megakaryocytes from patients with idiopathic thrombocytopenic purpura
Ewout J. Houwerzijl,Nel R. Blom,Johannes J. L. van der Want,Mariet T. Esselink,Jan J. Koornstra,Jan W. Smit,Henk Louwes,Edo Vellenga,Joost Th. M. de Wolf
Imatinib mesylate affects the development and function of dendritic cells generated from CD34+ peripheral blood progenitor cells
Silke Appel,Andreas M. Boehmler,Frank Grünebach,Martin R. Müller,Anette Rupf,Markus M. Weck,Ulrike Hartmann,Volker L. Reichardt,Lothar Kanz,Tim H. Brümmendorf,Peter Brossart
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
Congenital thrombotic thrombocytopenic purpura in association with a mutation in the second CUB domain of ADAMTS13
Clinical Trials & Observations
Brief Report
IMMUNOBIOLOGY
Naturally occurring anti–IFN-γ autoantibody and severe infections with Mycobacterium cheloneae and Burkholderia cocovenenans
Clinical Trials & Observations
Brief Report
Conny Höflich,Robert Sabat,Simone Rosseau,Bettina Temmesfeld,Hortense Slevogt,Wolf-Dietrich Döcke,Gerald Grütz,Christian Meisel,Elke Halle,Ulf B. Göbel,Hans-Dieter Volk,Norbert Suttorp
NEOPLASIA
Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway
Catherine Kern,Jean-François Cornuel,Christian Billard,Ruoping Tang,Danielle Rouillard,Virginie Stenou,Thierry Defrance,Florence Ajchenbaum-Cymbalista,Pierre-Yves Simonin,Sophie Feldblum,Jean-Pierre Kolb
Prognostic significance of bcl-xL gene expression and apoptotic cell counts in follicular lymphoma
Clinical Trials & Observations
Brief Report
Wei-Li Zhao,Marjan Ertault Daneshpouy,Nicolas Mounier,Josette Brière,Christophe Leboeuf,Louis-François Plassa,Elisabeth Turpin,Jean-Michel Cayuela,Jean-Claude Ameisen,Christian Gisselbrecht,Anne Janin
RED CELLS
TRANSPLANTATION
Treosulfan and fludarabine: a new toxicity-reduced conditioning regimen for allogeneic hematopoietic stem cell transplantation
Jochen Casper,Wolfgang Knauf,Thomas Kiefer,Daniel Wolff,Beate Steiner,Ulrich Hammer,Rudolf Wegener,Hans-Dieter Kleine,Stefan Wilhelm,Agnes Knopp,Gernot Hartung,Gottfried Dölken,Mathias Freund
Graft-versus-host-reactive donor CD4 cells can induce T cell-mediated rejection of the donor marrow in mixed allogeneic chimeras prepared with nonmyeloablative conditioning
Yong-Mi Kim,Markus Y. Mapara,Julian D. Down,Kevin W. Johnson,Florence Boisgerault,Yoshinobu Akiyama,Gilles Benichou,Michele Pelot,Guiling Zhao,Megan Sykes
CORRESPONDENCE
-
Cover Image
Cover Image
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals